The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC)

BACKGROUND. With the aging population, hepatocellular carcinoma (HCC) in the elderly represents a significant health burden. We aimed to evaluate and compare the efficacy and tolerability of single-agent sorafenib in treating elderly patients with advanced HCC versus the younger population. METHODS....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wong, Hilda, Tang, Yuen Fong, Yao, Tzy-Jyun, Chiu, Joanne, Leung, Roland, Chan, Pierre, Cheung, Tan To, Chan, Albert C., Pang, Roberta W., Poon, Ronnie, Fan, Sheung-Tat, Yau, Thomas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AlphaMed Press 2011
Konular:
Geriatric Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3248771/
https://ncbi.nlm.nih.gov/pubmed/22135121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0192
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller